Revolutionary Clinical Trial Restores Vision by Healing Irreversible Eye Damage

A groundbreaking stem cell therapy, CALEC, shows promise in healing severe corneal injuries, particularly benefiting Black patients facing donor matching challenges. This treatment utilizes a patient's own stem cells for corneal repair, boasting a 90% success rate. Ongoing research aims to further enhance accessibility and address disparities in eye health.